Bloomberg Law
April 14, 2020, 6:34 PM

Opioid Overdose Treatment Drug Company Axes Top Lawyer

Brian Baxter
Brian Baxter

Amphastar Pharmaceuticals Inc.'s longtime legal head has left the company as part of an effort to simplify management by “removing a layer” from its organizational structure.

Jason Shandell, general counsel since December 2008 and president of Amphastar since June 2013, resigned April 10 from both roles, as well as his position as a member of the specialty pharmaceutical company’s board of directors, according to a Monday press release and securities filing by Amphastar.

Shandell will receive nearly $2.43 million in cash severance and Amphastar has agreed to vest 80% of its unvested stock options and restricted stock units, the generic ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.